-
1
-
-
0037972522
-
Mitochondrial respiratory-chain diseases
-
DOI 10.1056/NEJMra022567
-
DiMauro, S.; Schon, E.A., Mitochondrial respiratory-chain diseases. N Engl J Med, 2003, 348(26), 2656-2668. (Pubitemid 36741594)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.26
, pp. 2656-2668
-
-
DiMauro, S.1
Schon, E.A.2
-
2
-
-
33745274726
-
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
-
DOI 10.1016/j.cell.2006.06.010, PII S0092867406007689
-
Chan, D.C., Mitochondria: dynamic organelles in disease, aging, and development. Cell, 2006, 125(7), 1241-1252. (Pubitemid 43929096)
-
(2006)
Cell
, vol.125
, Issue.7
, pp. 1241-1252
-
-
Chan, D.C.1
-
3
-
-
65849373277
-
Oxidative stress induces degradation of mitochondrial DNA
-
Shokolenko, I.; Venediktova, N.; Bochkareva, A.; Wilson, G.L.; Alexeyev, M.F., Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res, 2009, 37(8), 2539-2548.
-
(2009)
Nucleic Acids Res
, vol.37
, Issue.8
, pp. 2539-2548
-
-
Shokolenko, I.1
Venediktova, N.2
Bochkareva, A.3
Wilson, G.L.4
Alexeyev, M.F.5
-
4
-
-
0142150051
-
Mitochondrial formation of reactive oxygen species
-
DOI 10.1113/jphysiol.2003.049478
-
Turrens, J.F., Mitochondrial formation of reactive oxygen species. J Physiol, 2003, 552(Pt 2), 335-344. (Pubitemid 37321833)
-
(2003)
Journal of Physiology
, vol.552
, Issue.2
, pp. 335-344
-
-
Turrens, J.F.1
-
5
-
-
0033796008
-
Regulation of ubiquinone metabolism
-
Dallner, G.; Sindelar, P.J., Regulation of ubiquinone metabolism. Free Radic Biol Med, 2000, 29(3-4), 285-294.
-
(2000)
Free Radic Biol Med
, vol.29
, Issue.3-4
, pp. 285-294
-
-
Dallner, G.1
Sindelar, P.J.2
-
6
-
-
84865157772
-
Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects
-
Gutierrez-Mariscal, F.M.; Perez-Martinez, P.; Delgado-Lista, J.; Yubero-Serrano, E.M.; Camargo, A.; Delgado-Casado, N.; Cruz-Teno, C.; Santos-Gonzalez, M.; Rodriguez-Cantalejo, F.; Castano, J.P.; Villalba-Montoro, J.M.; Fuentes, F.; Perez-Jimenez, F.; Lopez-Miranda, J., Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. Age (Dordr), 2011.
-
(2011)
Age (Dordr)
-
-
Gutierrez-Mariscal, F.M.1
Perez-Martinez, P.2
Delgado-Lista, J.3
Yubero-Serrano, E.M.4
Camargo, A.5
Delgado-Casado, N.6
Cruz-Teno, C.7
Santos-Gonzalez, M.8
Rodriguez-Cantalejo, F.9
Castano, J.P.10
Villalba-Montoro, J.M.11
Fuentes, F.12
Perez-Jimenez, F.13
Lopez-Miranda, J.14
-
7
-
-
78650881903
-
Coenzyme Q as an antiadipogenic factor
-
Bour, S.; Carmona, M.C.; Galinier, A.; Caspar-Bauguil, S.; Van Gaal, L.; Staels, B.; Penicaud, L.; Casteilla, L., Coenzyme Q as an antiadipogenic factor. Antioxid Redox Signal, 2011, 14(3), 403-413.
-
(2011)
Antioxid Redox Signal
, vol.14
, Issue.3
, pp. 403-413
-
-
Bour, S.1
Carmona, M.C.2
Galinier, A.3
Caspar-Bauguil, S.4
Van Gaal, L.5
Staels, B.6
Penicaud, L.7
Casteilla, L.8
-
8
-
-
79958002852
-
Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: A randomized controlled trial
-
Dai, Y.L.; Luk, T.H.; Yiu, K.H.; Wang, M.; Yip, P.M.; Lee, S.W.; Li, S.W.; Tam, S.; Fong, B.; Lau, C.P.; Siu, C.W.; Tse, H.F., Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: A randomized controlled trial. Atherosclerosis, 2011, 216(2), 395-401.
-
(2011)
Atherosclerosis
, vol.216
, Issue.2
, pp. 395-401
-
-
Dai, Y.L.1
Luk, T.H.2
Yiu, K.H.3
Wang, M.4
Yip, P.M.5
Lee, S.W.6
Li, S.W.7
Tam, S.8
Fong, B.9
Lau, C.P.10
Siu, C.W.11
Tse, H.F.12
-
9
-
-
78049283800
-
Coenzyme Q10: A novel gastroprotective effect via modulation of vascular permeability, prostaglandin E, nitric oxide and redox status in indomethacin-induced gastric ulcer model
-
El-Abhar, H.S., Coenzyme Q10: a novel gastroprotective effect via modulation of vascular permeability, prostaglandin E, nitric oxide and redox status in indomethacin-induced gastric ulcer model. Eur J Pharmacol, 2010, 649(1-3), 314-319.
-
(2010)
Eur J Pharmacol
, vol.649
, Issue.1-3
, pp. 314-319
-
-
El-Abhar, H.S.1
-
10
-
-
34249826635
-
The Role of Coenzyme Q10 in Statin-Associated Myopathy. A Systematic Review
-
DOI 10.1016/j.jacc.2007.02.049, PII S0735109707010546
-
Marcoff, L.; Thompson, P.D., The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol, 2007, 49(23), 2231-2237. (Pubitemid 46856819)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.23
, pp. 2231-2237
-
-
Marcoff, L.1
Thompson, P.D.2
-
11
-
-
39949084143
-
Antifatigue effects of coenzyme Q10 during physical fatigue
-
Mizuno, K.; Tanaka, M.; Nozaki, S.; Mizuma, H.; Ataka, S.; Tahara, T.; Sugino, T.; Shirai, T.; Kajimoto, Y.; Kuratsune, H.; Kajimoto, O.; Watanabe, Y., Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition, 2008, 24(4), 293-299.
-
(2008)
Nutrition
, vol.24
, Issue.4
, pp. 293-299
-
-
Mizuno, K.1
Tanaka, M.2
Nozaki, S.3
Mizuma, H.4
Ataka, S.5
Tahara, T.6
Sugino, T.7
Shirai, T.8
Kajimoto, Y.9
Kuratsune, H.10
Kajimoto, O.11
Watanabe, Y.12
-
12
-
-
77949440226
-
Coenzyme Q10 in neuromuscular and neurodegenerative disorders
-
Mancuso, M.; Orsucci, D.; Volpi, L.; Calsolaro, V.; Siciliano, G., Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets, 2010, 11(1), 111-121.
-
(2010)
Curr Drug Targets
, vol.11
, Issue.1
, pp. 111-121
-
-
Mancuso, M.1
Orsucci, D.2
Volpi, L.3
Calsolaro, V.4
Siciliano, G.5
-
13
-
-
34250338864
-
Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia
-
DOI 10.1001/archneur.64.6.803
-
Di Prospero, N.A.; Sumner, C.J.; Penzak, S.R.; Ravina, B.; Fischbeck, K.H.; Taylor, J.P., Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia. Arch Neurol, 2007, 64(6), 803-808. (Pubitemid 46919834)
-
(2007)
Archives of Neurology
, vol.64
, Issue.6
, pp. 803-808
-
-
Di Prospero, N.A.1
Sumner, C.J.2
Penzak, S.R.3
Ravina, B.4
Fischbeck, K.H.5
Taylor, J.P.6
-
14
-
-
62549152383
-
Pharmacokinetics and metabolism of idebenone in healthy male subjects
-
Bodmer, M.; Vankan, P.; Dreier, M.; Kutz, K.W.; Drewe, J., Pharmacokinetics and metabolism of idebenone in healthy male subjects. Eur J Clin Pharmacol, 2009, 65(5), 493-501.
-
(2009)
Eur J Clin Pharmacol
, vol.65
, Issue.5
, pp. 493-501
-
-
Bodmer, M.1
Vankan, P.2
Dreier, M.3
Kutz, K.W.4
Drewe, J.5
-
15
-
-
0000701926
-
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria
-
DOI 10.1006/abbi.1996.0267
-
Esposti, M.D.; Ngo, A.; Ghelli, A.; Benelli, B.; Carelli, V.; McLennan, H.; Linnane, A.W., The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria. Arch Biochem Biophys, 1996, 330(2), 395-400. (Pubitemid 26172376)
-
(1996)
Archives of Biochemistry and Biophysics
, vol.330
, Issue.2
, pp. 395-400
-
-
Degli Esposti, M.1
Ngo, A.2
Ghelli, A.3
Benelli, B.4
Carelli, V.5
McLennan, H.6
Linnane, A.W.7
-
16
-
-
34248188655
-
The uptake and distribution of coenzyme Q10
-
Miles, M.V., The uptake and distribution of coenzyme Q10. Mitochondrion, 2007, 7 Suppl, S72-77.
-
(2007)
Mitochondrion
, vol.7
, Issue.SUPPL.
-
-
Miles, M.V.1
-
17
-
-
33645099245
-
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
-
Bhagavan, H.N.; Chopra, R.K., Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res, 2006, 40(5), 445-453.
-
(2006)
Free Radic Res
, vol.40
, Issue.5
, pp. 445-453
-
-
Bhagavan, H.N.1
Chopra, R.K.2
-
18
-
-
26944493846
-
Coenzyme Q10
-
Bonakdar, R.A.; Guarneri, E., Coenzyme Q10. Am Fam Physician, 2005, 72(6), 1065-1070. (Pubitemid 43093261)
-
(2005)
American Family Physician
, vol.72
, Issue.6
, pp. 1065-1070
-
-
Bonakdar, R.A.1
Guarneri, E.2
-
19
-
-
33947586652
-
10 deficiency
-
DOI 10.1007/s11064-006-9222-8
-
Land, J.M.; Heales, S.J.; Duncan, A.J.; Hargreaves, I.P., Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency. Neurochem Res, 2007, 32(4-5), 837-843. (Pubitemid 46481312)
-
(2007)
Neurochemical Research
, vol.32
, Issue.4-5
, pp. 837-843
-
-
Land, J.M.1
Heales, S.J.R.2
Duncan, A.J.3
Hargreaves, I.P.4
-
20
-
-
78649983485
-
Bioavailability enhancement of coenzyme Q10: An extensive review of patents
-
Beg, S.; Javed, S.; Kohli, K., Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Pat Drug Deliv Formul, 2010, 4(3), 245-255.
-
(2010)
Recent Pat Drug Deliv Formul
, vol.4
, Issue.3
, pp. 245-255
-
-
Beg, S.1
Javed, S.2
Kohli, K.3
-
21
-
-
63349103959
-
Watersoluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL)
-
Fetoni, A.R.; Piacentini, R.; Fiorita, A.; Paludetti, G.; Troiani, D., Watersoluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res, 2009, 1257, 108-116.
-
(2009)
Brain Res
, vol.1257
, pp. 108-116
-
-
Fetoni, A.R.1
Piacentini, R.2
Fiorita, A.3
Paludetti, G.4
Troiani, D.5
-
22
-
-
34248159898
-
Mitochondrial targeting of quinones: Therapeutic implications
-
DOI 10.1016/j.mito.2007.02.007, PII S1567724907000529, The Roled of Coenzyme Q in Cellular Metabolism: Current Biological and Clinical Aspects
-
Cocheme, H.M.; Kelso, G.F.; James, A.M.; Ross, M.F.; Trnka, J.; Mahendiran, T.; Asin-Cayuela, J.; Blaikie, F.H.; Manas, A.R.; Porteous, C.M.; Adlam, V.J.; Smith, R.A.; Murphy, M.P., Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion, 2007, 7 Suppl, S94-102. (Pubitemid 46722288)
-
(2007)
Mitochondrion
, vol.7
, Issue.SUPPL.
-
-
Cocheme, H.M.1
Kelso, G.F.2
James, A.M.3
Ross, M.F.4
Trnka, J.5
Mahendiran, T.6
Asin-Cayuela, J.7
Blaikie, F.H.8
Manas, A.-R.B.9
Porteous, C.M.10
Adlam, V.J.11
Smith, R.A.J.12
Murphy, M.P.13
-
23
-
-
20444392739
-
Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species: Implications for the use of exogenous ubiquinones as therapies and experimental tools
-
DOI 10.1074/jbc.M501527200
-
James, A.M.; Cocheme, H.M.; Smith, R.A.; Murphy, M.P., Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem, 2005, 280(22), 21295-21312. (Pubitemid 40805692)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.22
, pp. 21295-21312
-
-
James, A.M.1
Cocheme, H.M.2
Smith, R.A.J.3
Murphy, M.P.4
-
24
-
-
74149087396
-
Consequences of long-term oral administration of the mitochondria- targeted antioxidant MitoQ to wild-type mice
-
Rodriguez-Cuenca, S.; Cocheme, H.M.; Logan, A.; Abakumova, I.; Prime, T.A.; Rose, C.; Vidal-Puig, A.; Smith, A.C.; Rubinsztein, D.C.; Fearnley, I.M.; Jones, B.A.; Pope, S.; Heales, S.J.; Lam, B.Y.; Neogi, S.G.; McFarlane, I.; James, A.M.; Smith, R.A.; Murphy, M.P., Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med, 2010, 48(1), 161-172.
-
(2010)
Free Radic Biol Med
, vol.48
, Issue.1
, pp. 161-172
-
-
Rodriguez-Cuenca, S.1
Cocheme, H.M.2
Logan, A.3
Abakumova, I.4
Prime, T.A.5
Rose, C.6
Vidal-Puig, A.7
Smith, A.C.8
Rubinsztein, D.C.9
Fearnley, I.M.10
Jones, B.A.11
Pope, S.12
Heales, S.J.13
Lam, B.Y.14
Neogi, S.G.15
McFarlane, I.16
James, A.M.17
Smith, R.A.18
Murphy, M.P.19
-
25
-
-
39049156470
-
Prevalence of mitochondrial DNA disease in adults
-
DOI 10.1002/ana.21217
-
Schaefer, A.M.; McFarland, R.; Blakely, E.L.; He, L.; Whittaker, R.G.; Taylor, R.W.; Chinnery, P.F.; Turnbull, D.M., Prevalence of mitochondrial DNA disease in adults. Ann Neurol, 2008, 63(1), 35-39. (Pubitemid 351240549)
-
(2008)
Annals of Neurology
, vol.63
, Issue.1
, pp. 35-39
-
-
Schaefer, A.M.1
McFarland, R.2
Blakely, E.L.3
He, L.4
Whittaker, R.G.5
Taylor, R.W.6
Chinnery, P.F.7
Turnbull, D.M.8
-
26
-
-
73249119723
-
Diagnostic approach to mitochondrial disorders: The need for a reliable biomarker
-
Mancuso, M.; Orsucci, D.; Coppede, F.; Nesti, C.; Choub, A.; Siciliano, G., Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker. Curr Mol Med, 2009, 9(9), 1095-1107.
-
(2009)
Curr Mol Med
, vol.9
, Issue.9
, pp. 1095-1107
-
-
Mancuso, M.1
Orsucci, D.2
Coppede, F.3
Nesti, C.4
Choub, A.5
Siciliano, G.6
-
27
-
-
70149122589
-
CPEO and KSS differ in the percentage and location of the mtDNA deletion
-
Lopez-Gallardo, E.; Lopez-Perez, M.J.; Montoya, J.; Ruiz-Pesini, E., CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion, 2009, 9(5), 314-317.
-
(2009)
Mitochondrion
, vol.9
, Issue.5
, pp. 314-317
-
-
Lopez-Gallardo, E.1
Lopez-Perez, M.J.2
Montoya, J.3
Ruiz-Pesini, E.4
-
28
-
-
33748757300
-
Mitochondrial dysfunction, oxidative stress and neurodegeneration
-
Mancuso, M.; Coppede, F.; Migliore, L.; Siciliano, G.; Murri, L., Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis, 2006, 10(1), 59-73. (Pubitemid 44401367)
-
(2006)
Journal of Alzheimer's Disease
, vol.10
, Issue.1
, pp. 59-73
-
-
Mancuso, M.1
Coppede, F.2
Migliore, L.3
Siciliano, G.4
Murri, L.5
-
29
-
-
62249115660
-
Mitochondrial pathways for ROS formation and myocardial injury: The relevance of p66(Shc) and monoamine oxidase
-
Di Lisa, F.; Kaludercic, N.; Carpi, A.; Menabo, R.; Giorgio, M., Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol, 2009, 104(2), 131-139.
-
(2009)
Basic Res Cardiol
, vol.104
, Issue.2
, pp. 131-139
-
-
Di Lisa, F.1
Kaludercic, N.2
Carpi, A.3
Menabo, R.4
Giorgio, M.5
-
30
-
-
14744287295
-
10
-
DOI 10.1016/j.nbd.2004.10.021
-
Somayajulu, M.; McCarthy, S.; Hung, M.; Sikorska, M.; Borowy-Borowski, H.; Pandey, S., Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10. Neurobiol Dis, 2005, 18(3), 618-627. (Pubitemid 40332719)
-
(2005)
Neurobiology of Disease
, vol.18
, Issue.3
, pp. 618-627
-
-
Somayajulu, M.1
McCarthy, S.2
Hung, M.3
Sikorska, M.4
Borowy-Borowski, H.5
Pandey, S.6
-
31
-
-
79955954490
-
Loss of a conserved tyrosine residue of cytochrome b induces reactive oxygen species production by cytochrome BC1
-
Lee, D.W.; Selamoglu, N.; Lanciano, P.; Cooley, J.W.; Forquer, I.; Kramer, D.M.; Daldal, F., Loss of a conserved tyrosine residue of cytochrome b induces reactive oxygen species production by cytochrome BC1. J Biol Chem, 2011, 286(20), 18139-48.
-
(2011)
J Biol Chem
, vol.286
, Issue.20
, pp. 18139-18148
-
-
Lee, D.W.1
Selamoglu, N.2
Lanciano, P.3
Cooley, J.W.4
Forquer, I.5
Kramer, D.M.6
Daldal, F.7
-
32
-
-
28444445608
-
Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA
-
DOI 10.1016/j.neulet.2005.08.049, PII S030439400500995X
-
Vives-Bauza, C.; Gonzalo, R.; Manfredi, G.; Garcia-Arumi, E.; Andreu, A.L., Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett, 2006, 391(3), 136-141. (Pubitemid 41736187)
-
(2006)
Neuroscience Letters
, vol.391
, Issue.3
, pp. 136-141
-
-
Vives-Bauza, C.1
Gonzalo, R.2
Manfredi, G.3
Garcia-Arumi, E.4
Andreu, A.L.5
-
33
-
-
13844276595
-
Glutathione deficiency in patients with mitochondrial disease: Implications for pathogenesis and treatment
-
DOI 10.1007/s10545-005-4160-1
-
Hargreaves, I.P.; Sheena, Y.; Land, J.M.; Heales, S.J., Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment. J Inherit Metab Dis, 2005, 28(1), 81-88. (Pubitemid 40253986)
-
(2005)
Journal of Inherited Metabolic Disease
, vol.28
, Issue.1
, pp. 81-88
-
-
Hargreaves, I.P.1
Sheena, Y.2
Land, J.M.3
Heales, S.J.R.4
-
34
-
-
62649107795
-
Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia
-
Atkuri, K.R.; Cowan, T.M.; Kwan, T.; Ng, A.; Herzenberg, L.A.; Enns, G.M., Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci U S A, 2009, 106(10), 3941-3945.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.10
, pp. 3941-3945
-
-
Atkuri, K.R.1
Cowan, T.M.2
Kwan, T.3
Ng, A.4
Herzenberg, L.A.5
Enns, G.M.6
-
35
-
-
77954455562
-
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation
-
Mancuso, M.; Orsucci, D.; Logerfo, A.; Rocchi, A.; Petrozzi, L.; Nesti, C.; Galetta, F.; Santoro, G.; Murri, L.; Siciliano, G., Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol, 2010, 257(5), 774-781.
-
(2010)
J Neurol
, vol.257
, Issue.5
, pp. 774-781
-
-
Mancuso, M.1
Orsucci, D.2
Logerfo, A.3
Rocchi, A.4
Petrozzi, L.5
Nesti, C.6
Galetta, F.7
Santoro, G.8
Murri, L.9
Siciliano, G.10
-
36
-
-
77956509964
-
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction
-
Orsucci, D.; Filosto, M.; Siciliano, G.; Mancuso, M., Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction. Nutr Rev, 2009, 67(8), 427-438.
-
(2009)
Nutr Rev
, vol.67
, Issue.8
, pp. 427-438
-
-
Orsucci, D.1
Filosto, M.2
Siciliano, G.3
Mancuso, M.4
-
37
-
-
33645524333
-
Treatment for mitochondrial disorders
-
Chinnery, P.; Majamaa, K.; Turnbull, D.; Thorburn, D., Treatment for mitochondrial disorders. Cochrane Database Syst Rev, 2006(1), CD004426.
-
(2006)
Cochrane Database Syst Rev
, Issue.1
-
-
Chinnery, P.1
Majamaa, K.2
Turnbull, D.3
Thorburn, D.4
-
38
-
-
74249105071
-
Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy
-
Sacconi, S.; Trevisson, E.; Salviati, L.; Ayme, S.; Rigal, O.; Redondo, A.G.; Mancuso, M.; Siciliano, G.; Tonin, P.; Angelini, C.; Aure, K.; Lombes, A.; Desnuelle, C., Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord, 2010, 20(1), 44-48.
-
(2010)
Neuromuscul Disord
, vol.20
, Issue.1
, pp. 44-48
-
-
Sacconi, S.1
Trevisson, E.2
Salviati, L.3
Ayme, S.4
Rigal, O.5
Redondo, A.G.6
Mancuso, M.7
Siciliano, G.8
Tonin, P.9
Angelini, C.10
Aure, K.11
Lombes, A.12
Desnuelle, C.13
-
39
-
-
0030612535
-
Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study
-
Chen, R.S.; Huang, C.C.; Chu, N.S., Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur Neurol, 1997, 37(4), 212-218.
-
(1997)
Eur Neurol
, vol.37
, Issue.4
, pp. 212-218
-
-
Chen, R.S.1
Huang, C.C.2
Chu, N.S.3
-
40
-
-
78149325680
-
A randomized trial of coenzyme Q10 in mitochondrial disorders
-
Glover, E.I.; Martin, J.; Maher, A.; Thornhill, R.E.; Moran, G.R.; Tarnopolsky, M.A., A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve, 2010, 42(5), 739-748.
-
(2010)
Muscle Nerve
, vol.42
, Issue.5
, pp. 739-748
-
-
Glover, E.I.1
Martin, J.2
Maher, A.3
Thornhill, R.E.4
Moran, G.R.5
Tarnopolsky, M.A.6
-
41
-
-
33847404036
-
10 biosynthetic genes
-
DOI 10.1172/JCI31423
-
DiMauro, S.; Quinzii, C.M.; Hirano, M., Mutations in coenzyme Q10 biosynthetic genes. J Clin Invest, 2007, 117(3), 587-589. (Pubitemid 46348513)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.3
, pp. 587-589
-
-
DiMauro, S.1
Quinzii, C.M.2
Hirano, M.3
-
42
-
-
58149400513
-
Human CoQ10 deficiencies
-
Quinzii, C.M.; Lopez, L.C.; Naini, A.; DiMauro, S.; Hirano, M., Human CoQ10 deficiencies. Biofactors, 2008, 32(1-4), 113-118.
-
(2008)
Biofactors
, vol.32
, Issue.1-4
, pp. 113-118
-
-
Quinzii, C.M.1
Lopez, L.C.2
Naini, A.3
Dimauro, S.4
Hirano, M.5
-
43
-
-
34248171499
-
The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene
-
DOI 10.1093/brain/awm054
-
Gempel, K.; Topaloglu, H.; Talim, B.; Schneiderat, P.; Schoser, B.G.; Hans, V.H.; Palmafy, B.; Kale, G.; Tokatli, A.; Quinzii, C.; Hirano, M.; Naini, A.; DiMauro, S.; Prokisch, H.; Lochmuller, H.; Horvath, R., The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electrontransferring- flavoprotein dehydrogenase (ETFDH) gene. Brain, 2007, 130(Pt 8), 2037-2044. (Pubitemid 47236610)
-
(2007)
Brain
, vol.130
, Issue.8
, pp. 2037-2044
-
-
Gempel, K.1
Topaloglu, H.2
Talim, B.3
Schneiderat, P.4
Schoser, B.G.H.5
Hans, V.H.6
Palmafy, B.7
Kale, G.8
Tokatli, A.9
Quinzii, C.10
Hirano, M.11
Naini, A.12
DiMauro, S.13
Prokisch, H.14
Lochmuller, H.15
Horvath, R.16
-
44
-
-
65549087610
-
A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: A potentially treatable form of mitochondrial disease
-
Duncan, A.J.; Bitner-Glindzicz, M.; Meunier, B.; Costello, H.; Hargreaves, I.P.; Lopez, L.C.; Hirano, M.; Quinzii, C.M.; Sadowski, M.I.; Hardy, J.; Singleton, A.; Clayton, P.T.; Rahman, S., A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet, 2009, 84(5), 558-566.
-
(2009)
Am J Hum Genet
, vol.84
, Issue.5
, pp. 558-566
-
-
Duncan, A.J.1
Bitner-Glindzicz, M.2
Meunier, B.3
Costello, H.4
Hargreaves, I.P.5
Lopez, L.C.6
Hirano, M.7
Quinzii, C.M.8
Sadowski, M.I.9
Hardy, J.10
Singleton, A.11
Clayton, P.T.12
Rahman, S.13
-
45
-
-
41149121580
-
10 Deficiency
-
DOI 10.1016/j.ajhg.2007.12.024, PII S0002929708001523
-
Lagier-Tourenne, C.; Tazir, M.; Lopez, L.C.; Quinzii, C.M.; Assoum, M.; Drouot, N.; Busso, C.; Makri, S.; Ali-Pacha, L.; Benhassine, T.; Anheim, M.; Lynch, D.R.; Thibault, C.; Plewniak, F.; Bianchetti, L.; Tranchant, C.; Poch, O.; DiMauro, S.; Mandel, J.L.; Barros, M.H.; Hirano, M.; Koenig, M., ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet, 2008, 82(3), 661-672. (Pubitemid 351735958)
-
(2008)
American Journal of Human Genetics
, vol.82
, Issue.3
, pp. 661-672
-
-
Lagier-Tourenne, C.1
Tazir, M.2
Lopez, L.C.3
Quinzii, C.M.4
Assoum, M.5
Drouot, N.6
Busso, C.7
Makri, S.8
Ali-Pacha, L.9
Benhassine, T.10
Anheim, M.11
Lynch, D.R.12
Thibault, C.13
Plewniak, F.14
Bianchetti, L.15
Tranchant, C.16
Poch, O.17
DiMauro, S.18
Mandel, J.-L.19
Barros, M.H.20
Hirano, M.21
Koenig, M.22
more..
-
46
-
-
41149134880
-
CABC1 Gene Mutations Cause Ubiquinone Deficiency with Cerebellar Ataxia and Seizures
-
DOI 10.1016/j.ajhg.2007.12.022, PII S000292970800147X
-
Mollet, J.; Delahodde, A.; Serre, V.; Chretien, D.; Schlemmer, D.; Lombes, A.; Boddaert, N.; Desguerre, I.; de Lonlay, P.; de Baulny, H.O.; Munnich, A.; Rotig, A., CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet, 2008, 82(3), 623-630. (Pubitemid 351735957)
-
(2008)
American Journal of Human Genetics
, vol.82
, Issue.3
, pp. 623-630
-
-
Mollet, J.1
Delahodde, A.2
Serre, V.3
Chretien, D.4
Schlemmer, D.5
Lombes, A.6
Boddaert, N.7
Desguerre, I.8
De Lonlay, P.9
Ogier De Baulny, H.10
Munnich, A.11
Rotig, A.12
-
47
-
-
33846446004
-
Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1
-
DOI 10.1212/01.wnl.0000252366.10731.43, PII 0000611420070123000015
-
Le Ber, I.; Dubourg, O.; Benoist, J.F.; Jardel, C.; Mochel, F.; Koenig, M.; Brice, A.; Lombes, A.; Durr, A., Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology, 2007, 68(4), 295-297. (Pubitemid 46148344)
-
(2007)
Neurology
, vol.68
, Issue.4
, pp. 295-297
-
-
Le Ber, I.1
Dubourg, O.2
Benoist, J.-F.3
Jardel, C.4
Mochel, F.5
Koenig, M.6
Brice, A.7
Lombes, A.8
Durr, A.9
-
48
-
-
80052695641
-
Ataxia with oculomotor apraxia type1 (AOA1): Novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients
-
Castellotti, B.; Mariotti, C.; Rimoldi, M.; Fancellu, R.; Plumari, M.; Caimi, S.; Uziel, G.; Nardocci, N.; Moroni, I.; Zorzi, G.; Pareyson, D.; Di Bella, D.; Di Donato, S.; Taroni, F.; Gellera, C., Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. Neurogenetics, 2011.
-
(2011)
Neurogenetics
-
-
Castellotti, B.1
Mariotti, C.2
Rimoldi, M.3
Fancellu, R.4
Plumari, M.5
Caimi, S.6
Uziel, G.7
Nardocci, N.8
Moroni, I.9
Zorzi, G.10
Pareyson, D.11
Di Bella, D.12
Di Donato, S.13
Taroni, F.14
Gellera, C.15
-
49
-
-
77957844254
-
Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency
-
Quinzii, C.M.; Lopez, L.C.; Gilkerson, R.W.; Dorado, B.; Coku, J.; Naini, A.B.; Lagier-Tourenne, C.; Schuelke, M.; Salviati, L.; Carrozzo, R.; Santorelli, F.; Rahman, S.; Tazir, M.; Koenig, M.; DiMauro, S.; Hirano, M., Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J, 2010, 24(10), 3733-3743.
-
(2010)
FASEB J
, vol.24
, Issue.10
, pp. 3733-3743
-
-
Quinzii, C.M.1
Lopez, L.C.2
Gilkerson, R.W.3
Dorado, B.4
Coku, J.5
Naini, A.B.6
Lagier-Tourenne, C.7
Schuelke, M.8
Salviati, L.9
Carrozzo, R.10
Santorelli, F.11
Rahman, S.12
Tazir, M.13
Koenig, M.14
Dimauro, S.15
Hirano, M.16
-
50
-
-
77955594306
-
Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: Time-and compound-dependent effects
-
Lopez, L.C.; Quinzii, C.M.; Area, E.; Naini, A.; Rahman, S.; Schuelke, M.; Salviati, L.; Dimauro, S.; Hirano, M., Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time-and compound-dependent effects. PLoS One, 2010, 5(7), e11897.
-
(2010)
PLoS One
, vol.5
, Issue.7
-
-
Lopez, L.C.1
Quinzii, C.M.2
Area, E.3
Naini, A.4
Rahman, S.5
Schuelke, M.6
Salviati, L.7
Dimauro, S.8
Hirano, M.9
-
51
-
-
13344270899
-
Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
-
Campuzano, V.; Montermini, L.; Molto, M.D.; Pianese, L.; Cossee, M.; Cavalcanti, F.; Monros, E.; Rodius, F.; Duclos, F.; Monticelli, A.; Zara, F.; Canizares, J.; Koutnikova, H.; Bidichandani, S.I.; Gellera, C.; Brice, A.; Trouillas, P.; De Michele, G.; Filla, A.; De Frutos, R.; Palau, F.; Patel, P.I.; Di Donato, S.; Mandel, J.L.; Cocozza, S.; Koenig, M.; Pandolfo, M., Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science, 1996, 271(5254), 1423-1427. (Pubitemid 26089479)
-
(1996)
Science
, vol.271
, Issue.5254
, pp. 1423-1427
-
-
Campuzano, V.1
Montermini, L.2
Molto, M.D.3
Pianese, L.4
Cossee, M.5
Cavalcanti, F.6
Monros, E.7
Rodius, F.8
Duclos, F.9
Monticelli, A.10
Zara, F.11
Canizares, J.12
Koutnikova, H.13
Bidichandani, S.I.14
Gellera, C.15
Brice, A.16
Trouillas, P.17
De Michele, G.18
Filla, A.19
De Frutos, R.20
Palau, F.21
Patel, P.I.22
Di Donato, S.23
Mandel, J.-L.24
Cocozza, S.25
Koenig, M.26
Pandolfo, M.27
more..
-
52
-
-
33846882183
-
Clinical features and molecular genetics of autosomal recessive cerebellar ataxias
-
DOI 10.1016/S1474-4422(07)70054-6, PII S1474442207700546
-
Fogel, B.L.; Perlman, S., Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol, 2007, 6(3), 245-257. (Pubitemid 46228080)
-
(2007)
Lancet Neurology
, vol.6
, Issue.3
, pp. 245-257
-
-
Fogel, B.L.1
Perlman, S.2
-
53
-
-
64249142672
-
The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood
-
Kipps, A.; Alexander, M.; Colan, S.D.; Gauvreau, K.; Smoot, L.; Crawford, L.; Darras, B.T.; Blume, E.D., The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr Cardiol, 2009, 30(3), 306-310.
-
(2009)
Pediatr Cardiol
, vol.30
, Issue.3
, pp. 306-310
-
-
Kipps, A.1
Alexander, M.2
Colan, S.D.3
Gauvreau, K.4
Smoot, L.5
Crawford, L.6
Darras, B.T.7
Blume, E.D.8
-
54
-
-
54049142098
-
Friedreich ataxia
-
Pandolfo, M., Friedreich ataxia. Arch Neurol, 2008, 65(10), 1296-1303.
-
(2008)
Arch Neurol
, vol.65
, Issue.10
, pp. 1296-1303
-
-
Pandolfo, M.1
-
55
-
-
57049116558
-
Predictors of progression in patients with Friedreich ataxia
-
La Pean, A.; Jeffries, N.; Grow, C.; Ravina, B.; Di Prospero, N.A., Predictors of progression in patients with Friedreich ataxia. Mov Disord, 2008, 23(14), 2026-2032.
-
(2008)
Mov Disord
, vol.23
, Issue.14
, pp. 2026-2032
-
-
La Pean, A.1
Jeffries, N.2
Grow, C.3
Ravina, B.4
Di Prospero, N.A.5
-
56
-
-
9844222853
-
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes
-
DOI 10.1093/hmg/6.11.1771
-
Campuzano, V.; Montermini, L.; Lutz, Y.; Cova, L.; Hindelang, C.; Jiralerspong, S.; Trottier, Y.; Kish, S.J.; Faucheux, B.; Trouillas, P.; Authier, F.J.; Durr, A.; Mandel, J.L.; Vescovi, A.; Pandolfo, M.; Koenig, M., Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet, 1997, 6(11), 1771-1780. (Pubitemid 27460350)
-
(1997)
Human Molecular Genetics
, vol.6
, Issue.11
, pp. 1771-1780
-
-
Campuzano, V.1
Montermini, L.2
Lutz, Y.3
Cova, L.4
Hindelang, C.5
Jiralerspong, S.6
Trottier, Y.7
Kish, S.J.8
Faucheux, B.9
Trouillas, P.10
Authier, F.J.11
Durr, A.12
Mandel, J.-L.13
Vescovi, A.14
Pandolfo, M.15
Koenig, M.16
-
57
-
-
67349165712
-
The role of iron in mitochondrial function
-
Levi, S.; Rovida, E., The role of iron in mitochondrial function. Biochim Biophys Acta, 2009, 1790(7), 629-636.
-
(2009)
Biochim Biophys Acta
, vol.1790
, Issue.7
, pp. 629-636
-
-
Levi, S.1
Rovida, E.2
-
58
-
-
76549093324
-
Iron-binding activity in yeast frataxin entails a trade off with stability in the alpha1/beta1 acidic ridge region
-
Correia, A.R.; Wang, T.; Craig, E.A.; Gomes, C.M., Iron-binding activity in yeast frataxin entails a trade off with stability in the alpha1/beta1 acidic ridge region. Biochem J, 2010, 426(2), 197-203.
-
(2010)
Biochem J
, vol.426
, Issue.2
, pp. 197-203
-
-
Correia, A.R.1
Wang, T.2
Craig, E.A.3
Gomes, C.M.4
-
59
-
-
70349504414
-
Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant
-
Huang, M.L.; Becker, E.M.; Whitnall, M.; Rahmanto, Y.S.; Ponka, P.; Richardson, D.R., Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc Natl Acad Sci U S A, 2009, 106(38), 16381-16386.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.38
, pp. 16381-16386
-
-
Huang, M.L.1
Becker, E.M.2
Whitnall, M.3
Rahmanto, Y.S.4
Ponka, P.5
Richardson, D.R.6
-
60
-
-
77951253200
-
The ins and outs of mitochondrial iron-loading: The metabolic defect in Friedreich's ataxia
-
Richardson, D.R.; Huang, M.L.; Whitnall, M.; Becker, E.M.; Ponka, P.; Rahmanto, Y.S., The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. J Mol Med, 2010, 88(4), 323-329.
-
(2010)
J Mol Med
, vol.88
, Issue.4
, pp. 323-329
-
-
Richardson, D.R.1
Huang, M.L.2
Whitnall, M.3
Becker, E.M.4
Ponka, P.5
Rahmanto, Y.S.6
-
61
-
-
70350622327
-
Friedreich's ataxia: Oxidative stress and cytoskeletal abnormalities
-
Sparaco, M.; Gaeta, L.M.; Santorelli, F.M.; Passarelli, C.; Tozzi, G.; Bertini, E.; Simonati, A.; Scaravilli, F.; Taroni, F.; Duyckaerts, C.; Feleppa, M.; Piemonte, F., Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci, 2009, 287(1-2), 111-118.
-
(2009)
J Neurol Sci
, vol.287
, Issue.1-2
, pp. 111-118
-
-
Sparaco, M.1
Gaeta, L.M.2
Santorelli, F.M.3
Passarelli, C.4
Tozzi, G.5
Bertini, E.6
Simonati, A.7
Scaravilli, F.8
Taroni, F.9
Duyckaerts, C.10
Feleppa, M.11
Piemonte, F.12
-
62
-
-
31544445770
-
Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity
-
DOI 10.1093/hmg/ddi461
-
Gakh, O.; Park, S.; Liu, G.; Macomber, L.; Imlay, J.A.; Ferreira, G.C.; Isaya, G., Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet, 2006, 15(3), 467-479. (Pubitemid 43159898)
-
(2006)
Human Molecular Genetics
, vol.15
, Issue.3
, pp. 467-479
-
-
Gakh, O.1
Park, S.2
Liu, G.3
Macomber, L.4
Imlay, J.A.5
Ferreira, G.C.6
Isaya, G.7
-
63
-
-
0033533071
-
Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study
-
DOI 10.1016/S0140-6736(99)01341-0
-
Rustin, P.; von Kleist-Retzow, J.C.; Chantrel-Groussard, K.; Sidi, D.; Munnich, A.; Rotig, A., Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet, 1999, 354(9177), 477-479. (Pubitemid 29368927)
-
(1999)
Lancet
, vol.354
, Issue.9177
, pp. 477-479
-
-
Rustin, P.1
Von Kleist-Retzow, J.-C.2
Chantrel-Groussard, K.3
Sidi, D.4
Munnich, A.5
Rotig, A.6
-
64
-
-
0033613262
-
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
-
DOI 10.1073/pnas.96.20.11492
-
Lodi, R.; Cooper, J.M.; Bradley, J.L.; Manners, D.; Styles, P.; Taylor, D.J.; Schapira, A.H., Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A, 1999, 96(20), 11492-11495. (Pubitemid 29487408)
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, Issue.20
, pp. 11492-11495
-
-
Lodi, R.1
Cooper, J.M.2
Bradley, J.L.3
Manners, D.4
Styles, P.5
Taylor, D.J.6
Schapira, A.H.V.7
-
65
-
-
1942501782
-
Mitochondrial DNA haplogroups influence the Friedreich's ataxia phenotype
-
Giacchetti, M.; Monticelli, A.; De Biase, I.; Pianese, L.; Turano, M.; Filla, A.; De Michele, G.; Cocozza, S., Mitochondrial DNA haplogroups influence the Friedreich's ataxia phenotype. J Med Genet, 2004, 41(4), 293-295. (Pubitemid 38496775)
-
(2004)
Journal of Medical Genetics
, vol.41
, Issue.4
, pp. 293-295
-
-
Giacchetti, M.1
Monticelli, A.2
De Biase, I.3
Pianese, L.4
Turano, M.5
Filla, A.6
De Michele, G.7
Cocozza, S.8
-
66
-
-
58149085962
-
Association between trinucleotide CAG repeats of the DNA polymerase gene (POLG) with age of onset of Iranian Friedreich's ataxia patients
-
Heidari, M.M.; Houshmand, M.; Hosseinkhani, S.; Nafissi, S.; Scheiber-Mojdehkar, B.; Khatami, M., Association between trinucleotide CAG repeats of the DNA polymerase gene (POLG) with age of onset of Iranian Friedreich's ataxia patients. Neurol Sci, 2008, 29(6), 489-493.
-
(2008)
Neurol Sci
, vol.29
, Issue.6
, pp. 489-493
-
-
Heidari, M.M.1
Houshmand, M.2
Hosseinkhani, S.3
Nafissi, S.4
Scheiber-Mojdehkar, B.5
Khatami, M.6
-
67
-
-
70349134309
-
Antioxidants and other pharmacological treatments for Friedreich ataxia
-
Kearney, M.; Orrell, R.W.; Fahey, M.; Pandolfo, M., Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev, 2009(4), CD007791.
-
(2009)
Cochrane Database Syst Rev
, Issue.4
-
-
Kearney, M.1
Orrell, R.W.2
Fahey, M.3
Pandolfo, M.4
-
68
-
-
14044273058
-
Friedreich ataxia: The oxidative stress paradox
-
DOI 10.1093/hmg/ddi042
-
Seznec, H.; Simon, D.; Bouton, C.; Reutenauer, L.; Hertzog, A.; Golik, P.; Procaccio, V.; Patel, M.; Drapier, J.C.; Koenig, M.; Puccio, H., Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet, 2005, 14(4), 463-474. (Pubitemid 40277462)
-
(2005)
Human Molecular Genetics
, vol.14
, Issue.4
, pp. 463-474
-
-
Seznec, H.1
Simon, D.2
Bouton, C.3
Reutenauer, L.4
Hertzog, A.5
Golik, P.6
Procaccio, V.7
Patel, M.8
Drapier, J.-C.9
Koenig, M.10
Puccio, H.11
-
69
-
-
0348136710
-
Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants
-
Jauslin, M.L.; Meier, T.; Smith, R.A.; Murphy, M.P., Mitochondria- targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J, 2003, 17(13), 1972-1974.
-
(2003)
FASEB J
, vol.17
, Issue.13
, pp. 1972-1974
-
-
Jauslin, M.L.1
Meier, T.2
Smith, R.A.3
Murphy, M.P.4
-
70
-
-
1842836406
-
A cellular model for Friedreich Ataxia revelas small-molecule glutathione peroxidase mimetics as novel treatment strategy
-
Jauslin, M.L.; Wirth, T.; Meier, T.; Schoumacher, F., A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet, 2002, 11(24), 3055-3063. (Pubitemid 35414819)
-
(2002)
Human Molecular Genetics
, vol.11
, Issue.24
, pp. 3055-3063
-
-
Jauslin, M.L.1
Wirth, T.2
Meier, T.3
Schoumacher, F.4
-
71
-
-
2542556601
-
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia
-
DOI 10.1093/hmg/ddh114
-
Seznec, H.; Simon, D.; Monassier, L.; Criqui-Filipe, P.; Gansmuller, A.; Rustin, P.; Koenig, M.; Puccio, H., Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum Mol Genet, 2004, 13(10), 1017-1024. (Pubitemid 38702188)
-
(2004)
Human Molecular Genetics
, vol.13
, Issue.10
, pp. 1017-1024
-
-
Seznec, H.1
Simon, D.2
Monassier, L.3
Criqui-Filipe, P.4
Gansmuller, A.5
Rustin, P.6
Koening, M.7
Puccio, H.8
-
72
-
-
0034642203
-
Oxidative stress in patients with Friedreich ataxia
-
Schulz, J.B.; Dehmer, T.; Schols, L.; Mende, H.; Hardt, C.; Vorgerd, M.; Burk, K.; Matson, W.; Dichgans, J.; Beal, M.F.; Bogdanov, M.B., Oxidative stress in patients with Friedreich ataxia. Neurology, 2000, 55(11), 1719-1721.
-
(2000)
Neurology
, vol.55
, Issue.11
, pp. 1719-1721
-
-
Schulz, J.B.1
Dehmer, T.2
Schols, L.3
Mende, H.4
Hardt, C.5
Vorgerd, M.6
Burk, K.7
Matson, W.8
Dichgans, J.9
Beal, M.F.10
Bogdanov, M.B.11
-
73
-
-
34248149391
-
10 and vitamin E therapy
-
DOI 10.1016/j.mito.2007.04.001, PII S1567724907000670, The Roled of Coenzyme Q in Cellular Metabolism: Current Biological and Clinical Aspects
-
Cooper, J.M.; Schapira, A.H., Friedreich's ataxia: coenzyme Q10 and vitamin E therapy. Mitochondrion, 2007, 7 Suppl, S127-135. (Pubitemid 46712240)
-
(2007)
Mitochondrion
, vol.7
, Issue.SUPPL.
-
-
Cooper, J.M.1
Schapira, A.H.V.2
-
74
-
-
0036554660
-
Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia
-
DOI 10.1080/10715760290021333
-
Rustin, P.; Rotig, A.; Munnich, A.; Sidi, D., Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia. Free Radic Res, 2002, 36(4), 467-469. (Pubitemid 35154096)
-
(2002)
Free Radical Research
, vol.36
, Issue.4
, pp. 467-469
-
-
Rustin, P.1
Rotig, A.2
Munnich, A.3
Sidi, D.4
-
75
-
-
0036221156
-
Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia
-
Hausse, A.O.; Aggoun, Y.; Bonnet, D.; Sidi, D.; Munnich, A.; Rotig, A.; Rustin, P., Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart, 2002, 87(4), 346-349. (Pubitemid 34270947)
-
(2002)
Heart
, vol.87
, Issue.4
, pp. 346-349
-
-
Hausse, A.O.1
Aggoun, Y.2
Bonnet, D.3
Sidi, D.4
Munnich, A.5
Rotig, A.6
Rustin, P.7
-
76
-
-
0037849955
-
Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial
-
Mariotti, C.; Solari, A.; Torta, D.; Marano, L.; Fiorentini, C.; Di Donato, S., Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology, 2003, 60(10), 1676-1679. (Pubitemid 36618100)
-
(2003)
Neurology
, vol.60
, Issue.10
, pp. 1676-1679
-
-
Mariotti, C.1
Solari, A.2
Torta, D.3
Marano, L.4
Fiorentini, C.5
Di Donato, S.6
-
77
-
-
34548606803
-
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial
-
DOI 10.1016/S1474-4422(07)70220-X, PII S147444220770220X
-
Di Prospero, N.A.; Baker, A.; Jeffries, N.; Fischbeck, K.H., Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol, 2007, 6(10), 878-886. (Pubitemid 47404985)
-
(2007)
Lancet Neurology
, vol.6
, Issue.10
, pp. 878-886
-
-
Di Prospero, N.A.1
Baker, A.2
Jeffries, N.3
Fischbeck, K.H.4
-
78
-
-
52249089314
-
Idebenone treatment in paediatric and adult patients with Friedreich ataxia: Long-term follow-up
-
Pineda, M.; Arpa, J.; Montero, R.; Aracil, A.; Dominguez, F.; Galvan, M.; Mas, A.; Martorell, L.; Sierra, C.; Brandi, N.; Garcia-Arumi, E.; Rissech, M.; Velasco, D.; Costa, J.A.; Artuch, R., Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. Eur J Paediatr Neurol, 2008, 12(6), 470-475.
-
(2008)
Eur J Paediatr Neurol
, vol.12
, Issue.6
, pp. 470-475
-
-
Pineda, M.1
Arpa, J.2
Montero, R.3
Aracil, A.4
Dominguez, F.5
Galvan, M.6
Mas, A.7
Martorell, L.8
Sierra, C.9
Brandi, N.10
Garcia-Arumi, E.11
Rissech, M.12
Velasco, D.13
Costa, J.A.14
Artuch, R.15
-
79
-
-
77953832142
-
Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia
-
Drinkard, B.E.; Keyser, R.E.; Paul, S.M.; Arena, R.; Plehn, J.F.; Yanovski, J.A.; Di Prospero, N.A., Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia. Arch Phys Med Rehabil, 2010, 91(7), 1044-1050.
-
(2010)
Arch Phys Med Rehabil
, vol.91
, Issue.7
, pp. 1044-1050
-
-
Drinkard, B.E.1
Keyser, R.E.2
Paul, S.M.3
Arena, R.4
Plehn, J.F.5
Yanovski, J.A.6
Di Prospero, N.A.7
-
80
-
-
79952451186
-
Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)
-
e631
-
Lagedrost, S.J.; Sutton, M.S.; Cohen, M.S.; Satou, G.M.; Kaufman, B.D.; Perlman, S.L.; Rummey, C.; Meier, T.; Lynch, D.R., Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Am Heart J, 2011, 161(3), 639-645 e631.
-
(2011)
Am Heart J
, vol.161
, Issue.3
, pp. 639-645
-
-
Lagedrost, S.J.1
Sutton, M.S.2
Cohen, M.S.3
Satou, G.M.4
Kaufman, B.D.5
Perlman, S.L.6
Rummey, C.7
Meier, T.8
Lynch, D.R.9
-
81
-
-
77955450939
-
A phase 3, double-blind, placebocontrolled trial of idebenone in friedreich ataxia
-
Lynch, D.R.; Perlman, S.L.; Meier, T., A phase 3, double-blind, placebocontrolled trial of idebenone in friedreich ataxia. Arch Neurol, 2010, 67(8), 941-947.
-
(2010)
Arch Neurol
, vol.67
, Issue.8
, pp. 941-947
-
-
Lynch, D.R.1
Perlman, S.L.2
Meier, T.3
-
82
-
-
20144389286
-
Antioxidant treatment of patients with Friedreich ataxia: Four-year follow-up
-
DOI 10.1001/archneur.62.4.621
-
Hart, P.E.; Lodi, R.; Rajagopalan, B.; Bradley, J.L.; Crilley, J.G.; Turner, C.; Blamire, A.M.; Manners, D.; Styles, P.; Schapira, A.H.; Cooper, J.M., Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol, 2005, 62(4), 621-626. (Pubitemid 40489896)
-
(2005)
Archives of Neurology
, vol.62
, Issue.4
, pp. 621-626
-
-
Hart, P.E.1
Lodi, R.2
Rajagopalan, B.3
Bradley, J.L.4
Crilley, J.G.5
Turner, C.6
Blamire, A.M.7
Manners, D.8
Styles, P.9
Schapira, A.H.V.10
Cooper, J.M.11
-
83
-
-
56049088295
-
Coenzyme Q10 and vitamin e deficiency in Friedreich's ataxia: Predictor of efficacy of vitamin e and coenzyme Q10 therapy
-
Cooper, J.M.; Korlipara, L.V.; Hart, P.E.; Bradley, J.L.; Schapira, A.H., Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol, 2008, 15(12), 1371-1379.
-
(2008)
Eur J Neurol
, vol.15
, Issue.12
, pp. 1371-1379
-
-
Cooper, J.M.1
Korlipara, L.V.2
Hart, P.E.3
Bradley, J.L.4
Schapira, A.H.5
-
84
-
-
39049121295
-
Drug Insight: Antioxidant therapy in inherited ataxias
-
DOI 10.1038/ncpneuro0704, PII NCPNEURO0704
-
Pandolfo, M., Drug Insight: antioxidant therapy in inherited ataxias. Nat Clin Pract Neurol, 2008, 4(2), 86-96. (Pubitemid 351248066)
-
(2008)
Nature Clinical Practice Neurology
, vol.4
, Issue.2
, pp. 86-96
-
-
Pandolfo, M.1
-
85
-
-
20844443983
-
L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial
-
DOI 10.1007/s00702-004-0216-x
-
Schols, L.; Zange, J.; Abele, M.; Schillings, M.; Skipka, G.; Kuntz-Hehner, S.; van Beekvelt, M.C.; Colier, W.N.; Muller, K.; Klockgether, T.; Przuntek, H.; Vorgerd, M., L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm, 2005, 112(6), 789-796. (Pubitemid 40655570)
-
(2005)
Journal of Neural Transmission
, vol.112
, Issue.6
, pp. 789-796
-
-
Schols, L.1
Zange, J.2
Abele, M.3
Schillings, M.4
Skipka, G.5
Kuntz-Hehner, S.6
Van Beekvelt, M.C.P.7
Colier, W.N.J.M.8
Muller, K.9
Klockgether, T.10
Przuntek, H.11
Vorgerd, M.12
-
86
-
-
67649213875
-
Diagnosis and treatment of Friedreich ataxia: A European perspective
-
Schulz, J.B.; Boesch, S.; Burk, K.; Durr, A.; Giunti, P.; Mariotti, C.; Pousset, F.; Schols, L.; Vankan, P.; Pandolfo, M., Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol, 2009, 5(4), 222-234.
-
(2009)
Nat Rev Neurol
, vol.5
, Issue.4
, pp. 222-234
-
-
Schulz, J.B.1
Boesch, S.2
Burk, K.3
Durr, A.4
Giunti, P.5
Mariotti, C.6
Pousset, F.7
Schols, L.8
Vankan, P.9
Pandolfo, M.10
-
87
-
-
79958285168
-
Current and emerging treatment options in the management of Friedreich ataxia
-
Mancuso, M.; Orsucci, D.; Choub, A.; Siciliano, G., Current and emerging treatment options in the management of Friedreich ataxia. Neuropsychiatr Dis Treat, 2010, 6, 491-499.
-
(2010)
Neuropsychiatr Dis Treat
, vol.6
, pp. 491-499
-
-
Mancuso, M.1
Orsucci, D.2
Choub, A.3
Siciliano, G.4
-
88
-
-
47849101646
-
Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease
-
Wadsworth, T.L.; Bishop, J.A.; Pappu, A.S.; Woltjer, R.L.; Quinn, J.F., Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J Alzheimers Dis, 2008, 14(2), 225-234. (Pubitemid 352040040)
-
(2008)
Journal of Alzheimer's Disease
, vol.14
, Issue.2
, pp. 225-234
-
-
Wadsworth, T.L.1
Bishop, J.A.2
Pappu, A.S.3
Woltjer, R.L.4
Quinn, J.F.5
-
89
-
-
70449513452
-
Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients
-
Isobe, C.; Abe, T.; Terayama, Y., Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients. Dement Geriatr Cogn Disord, 2009, 28(5), 449-454.
-
(2009)
Dement Geriatr Cogn Disord
, vol.28
, Issue.5
, pp. 449-454
-
-
Isobe, C.1
Abe, T.2
Terayama, Y.3
-
90
-
-
26244447857
-
CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats
-
DOI 10.1016/j.expneurol.2005.07.012, PII S0014488605002414
-
Moreira, P.I.; Santos, M.S.; Sena, C.; Nunes, E.; Seica, R.; Oliveira, C.R., CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol, 2005, 196(1), 112-119. (Pubitemid 41416653)
-
(2005)
Experimental Neurology
, vol.196
, Issue.1
, pp. 112-119
-
-
Moreira, P.I.1
Santos, M.S.2
Sena, C.3
Nunes, E.4
Seica, R.5
Oliveira, C.R.6
-
91
-
-
58149373850
-
Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: An in vivo volume MRI study
-
Li, G.; Jack, C.R.; Yang, X.F.; Yang, E.S., Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: an in vivo volume MRI study. Biofactors, 2008, 32(1-4), 169-178.
-
(2008)
Biofactors
, vol.32
, Issue.1-4
, pp. 169-178
-
-
Li, G.1
Jack, C.R.2
Yang, X.F.3
Yang, E.S.4
-
92
-
-
77950189527
-
Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer's disease
-
Yang, X.; Dai, G.; Li, G.; Yang, E.S., Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer's disease. J Mol Neurosci, 2010, 41(1), 110-113.
-
(2010)
J Mol Neurosci
, vol.41
, Issue.1
, pp. 110-113
-
-
Yang, X.1
Dai, G.2
Li, G.3
Yang, E.S.4
-
93
-
-
33646596554
-
Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats
-
DOI 10.1016/j.bbr.2006.03.009, PII S0166432806001628
-
Ishrat, T.; Khan, M.B.; Hoda, M.N.; Yousuf, S.; Ahmad, M.; Ansari, M.A.; Ahmad, A.S.; Islam, F., Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res, 2006, 171(1), 9-16. (Pubitemid 43728393)
-
(2006)
Behavioural Brain Research
, vol.171
, Issue.1
, pp. 9-16
-
-
Ishrat, T.1
Khan, M.B.2
Hoda, Md.N.3
Yousuf, S.4
Ahmad, M.5
Ansari, M.A.6
Ahmad, A.S.7
Islam, F.8
-
94
-
-
13844298846
-
10 and α-tocopherol improves learning in aged mice
-
DOI 10.1016/j.freeradbiomed.2004.11.014
-
McDonald, S.R.; Sohal, R.S.; Forster, M.J., Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice. Free Radic Biol Med, 2005, 38(6), 729-736. (Pubitemid 40249743)
-
(2005)
Free Radical Biology and Medicine
, vol.38
, Issue.6
, pp. 729-736
-
-
Mcdonald, S.R.1
Sohal, R.S.2
Forster, M.J.3
-
95
-
-
77956207531
-
Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons
-
Manczak, M.; Mao, P.; Calkins, M.J.; Cornea, A.; Reddy, A.P.; Murphy, M.P.; Szeto, H.H.; Park, B.; Reddy, P.H., Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis, 2010, 20 Suppl 2, S609-631.
-
(2010)
J Alzheimers Dis
, vol.20
, Issue.SUPPL. 2
-
-
Manczak, M.1
Mao, P.2
Calkins, M.J.3
Cornea, A.4
Reddy, A.P.5
Murphy, M.P.6
Szeto, H.H.7
Park, B.8
Reddy, P.H.9
-
96
-
-
72649106290
-
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
-
Hattingen, E.; Magerkurth, J.; Pilatus, U.; Mozer, A.; Seifried, C.; Steinmetz, H.; Zanella, F.; Hilker, R., Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain, 2009, 132(Pt 12), 3285-3297.
-
(2009)
Brain
, vol.132
, Issue.PART 12
, pp. 3285-3297
-
-
Hattingen, E.1
Magerkurth, J.2
Pilatus, U.3
Mozer, A.4
Seifried, C.5
Steinmetz, H.6
Zanella, F.7
Hilker, R.8
-
97
-
-
67649756320
-
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
-
Bueler, H., Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol, 2009, 218(2), 235-246.
-
(2009)
Exp Neurol
, vol.218
, Issue.2
, pp. 235-246
-
-
Bueler, H.1
-
98
-
-
0031859395
-
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
-
DOI 10.1002/ana.410440207
-
Gu, M.; Cooper, J.M.; Taanman, J.W.; Schapira, A.H., Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol, 1998, 44(2), 177-186. (Pubitemid 28374105)
-
(1998)
Annals of Neurology
, vol.44
, Issue.2
, pp. 177-186
-
-
Gu, M.1
Cooper, J.M.2
Taanman, J.W.3
Schapira, A.H.V.4
-
99
-
-
63449107606
-
Mitochondrial DNA sequence variation and neurodegeneration
-
Mancuso, M.; Filosto, M.; Orsucci, D.; Siciliano, G., Mitochondrial DNA sequence variation and neurodegeneration. Hum Genomics, 2008, 3(1), 71-78.
-
(2008)
Hum Genomics
, vol.3
, Issue.1
, pp. 71-78
-
-
Mancuso, M.1
Filosto, M.2
Orsucci, D.3
Siciliano, G.4
-
100
-
-
54249094205
-
The coenzyme Q10 status of the brain regions of Parkinson's disease patients
-
Hargreaves, I.P.; Lane, A.; Sleiman, P.M., The coenzyme Q10 status of the brain regions of Parkinson's disease patients. Neurosci Lett, 2008, 447(1), 17-19.
-
(2008)
Neurosci Lett
, vol.447
, Issue.1
, pp. 17-19
-
-
Hargreaves, I.P.1
Lane, A.2
Sleiman, P.M.3
-
101
-
-
72649092390
-
Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′- deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process
-
Isobe, C.; Abe, T.; Terayama, Y., Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett, 2010, 469(1), 159-163.
-
(2010)
Neurosci Lett
, vol.469
, Issue.1
, pp. 159-163
-
-
Isobe, C.1
Abe, T.2
Terayama, Y.3
-
102
-
-
2442497176
-
10 on the mitochondrial function of skin fibroblasts from Parkinson patients
-
DOI 10.1016/j.jns.2004.02.003, PII S0022510X04000322
-
Winkler-Stuck, K.; Wiedemann, F.R.; Wallesch, C.W.; Kunz, W.S., Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients. J Neurol Sci, 2004, 220(1-2), 41-48. (Pubitemid 38622096)
-
(2004)
Journal of the Neurological Sciences
, vol.220
, Issue.1-2
, pp. 41-48
-
-
Winkler-Stuck, K.1
Wiedemann, F.R.2
Wallesch, C.-W.3
Kunz, W.S.4
-
103
-
-
33646878524
-
Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons
-
Kooncumchoo, P.; Sharma, S.; Porter, J.; Govitrapong, P.; Ebadi, M., Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci, 2006, 28(2), 125-141.
-
(2006)
J Mol Neurosci
, vol.28
, Issue.2
, pp. 125-141
-
-
Kooncumchoo, P.1
Sharma, S.2
Porter, J.3
Govitrapong, P.4
Ebadi, M.5
-
104
-
-
0036771852
-
Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline
-
Shults, C.W.; Oakes, D.; Kieburtz, K.; Beal, M.F.; Haas, R.; Plumb, S.; Juncos, J.L.; Nutt, J.; Shoulson, I.; Carter, J.; Kompoliti, K.; Perlmutter, J.S.; Reich, S.; Stern, M.; Watts, R.L.; Kurlan, R.; Molho, E.; Harrison, M.; Lew, M., Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 2002, 59(10), 1541-1550.
-
(2002)
Arch Neurol
, vol.59
, Issue.10
, pp. 1541-1550
-
-
Shults, C.W.1
Oakes, D.2
Kieburtz, K.3
Beal, M.F.4
Haas, R.5
Plumb, S.6
Juncos, J.L.7
Nutt, J.8
Shoulson, I.9
Carter, J.10
Kompoliti, K.11
Perlmutter, J.S.12
Reich, S.13
Stern, M.14
Watts, R.L.15
Kurlan, R.16
Molho, E.17
Harrison, M.18
Lew, M.19
-
105
-
-
34447252358
-
10 in Parkinson disease
-
DOI 10.1001/archneur.64.7.nct60005
-
Storch, A.; Jost, W.H.; Vieregge, P.; Spiegel, J.; Greulich, W.; Durner, J.; Muller, T.; Kupsch, A.; Henningsen, H.; Oertel, W.H.; Fuchs, G.; Kuhn, W.; Niklowitz, P.; Koch, R.; Herting, B.; Reichmann, H., Randomized, doubleblind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol, 2007, 64(7), 938-944. (Pubitemid 47047992)
-
(2007)
Archives of Neurology
, vol.64
, Issue.7
, pp. 938-944
-
-
Storch, A.1
Jost, W.H.2
Vieregge, P.3
Spiegel, J.4
Greulich, W.5
Durner, J.6
MuLler, T.7
Kupsch, A.8
Henningsen, H.9
Oertel, W.H.10
Fuchs, G.11
Kuhn, W.12
Niklowitz, P.13
Koch, R.14
Herting, B.15
Reichmann, H.16
-
106
-
-
78049357951
-
Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model
-
Ghosh, A.; Chandran, K.; Kalivendi, S.V.; Joseph, J.; Antholine, W.E.; Hillard, C.J.; Kanthasamy, A.; Kalyanaraman, B., Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radic Biol Med, 2010, 49(11), 1674-1684.
-
(2010)
Free Radic Biol Med
, vol.49
, Issue.11
, pp. 1674-1684
-
-
Ghosh, A.1
Chandran, K.2
Kalivendi, S.V.3
Joseph, J.4
Antholine, W.E.5
Hillard, C.J.6
Kanthasamy, A.7
Kalyanaraman, B.8
-
107
-
-
77955792985
-
A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
-
Snow, B.J.; Rolfe, F.L.; Lockhart, M.M.; Frampton, C.M.; O'Sullivan, J.D.; Fung, V.; Smith, R.A.; Murphy, M.P.; Taylor, K.M., A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Disord, 2010, 25(11), 1670-1674.
-
(2010)
Mov Disord
, vol.25
, Issue.11
, pp. 1670-1674
-
-
Snow, B.J.1
Rolfe, F.L.2
Lockhart, M.M.3
Frampton, C.M.4
O'Sullivan, J.D.5
Fung, V.6
Smith, R.A.7
Murphy, M.P.8
Taylor, K.M.9
-
108
-
-
33846115045
-
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
-
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology, 2007, 68(1), 20-28.
-
(2007)
Neurology
, vol.68
, Issue.1
, pp. 20-28
-
-
-
109
-
-
49249087500
-
Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial
-
Stamelou, M.; Reuss, A.; Pilatus, U.; Magerkurth, J.; Niklowitz, P.; Eggert, K.M.; Krisp, A.; Menke, T.; Schade-Brittinger, C.; Oertel, W.H.; Hoglinger, G.U., Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord, 2008, 23(7), 942-949.
-
(2008)
Mov Disord
, vol.23
, Issue.7
, pp. 942-949
-
-
Stamelou, M.1
Reuss, A.2
Pilatus, U.3
Magerkurth, J.4
Niklowitz, P.5
Eggert, K.M.6
Krisp, A.7
Menke, T.8
Schade-Brittinger, C.9
Oertel, W.H.10
Hoglinger, G.U.11
-
110
-
-
77957742105
-
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease
-
Kim, J.; Moody, J.P.; Edgerly, C.K.; Bordiuk, O.L.; Cormier, K.; Smith, K.; Beal, M.F.; Ferrante, R.J., Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet, 2010, 19(20), 3919-3935.
-
(2010)
Hum Mol Genet
, vol.19
, Issue.20
, pp. 3919-3935
-
-
Kim, J.1
Moody, J.P.2
Edgerly, C.K.3
Bordiuk, O.L.4
Cormier, K.5
Smith, K.6
Beal, M.F.7
Ferrante, R.J.8
-
111
-
-
77954426314
-
Huntington's disease and mitochondrial alterations: Emphasis on experimental models
-
Perez-De la Cruz, V.; Carrillo-Mora, P.; Santamaria, A., Huntington's disease and mitochondrial alterations: emphasis on experimental models. J Bioenerg Biomembr, 2010, 42(3), 207-215.
-
(2010)
J Bioenerg Biomembr
, vol.42
, Issue.3
, pp. 207-215
-
-
Perez-De La Cruz, V.1
Carrillo-Mora, P.2
Santamaria, A.3
-
112
-
-
79951492653
-
Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease
-
Ciammola, A.; Sassone, J.; Sciacco, M.; Mencacci, N.E.; Ripolone, M.; Bizzi, C.; Colciago, C.; Moggio, M.; Parati, G.; Silani, V.; Malfatto, G., Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease. Mov Disord, 2011, 26(1), 130-137.
-
(2011)
Mov Disord
, vol.26
, Issue.1
, pp. 130-137
-
-
Ciammola, A.1
Sassone, J.2
Sciacco, M.3
Mencacci, N.E.4
Ripolone, M.5
Bizzi, C.6
Colciago, C.7
Moggio, M.8
Parati, G.9
Silani, V.10
Malfatto, G.11
-
113
-
-
29244483093
-
10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease
-
DOI 10.1016/j.neuint.2005.09.002, PII S0197018605002317
-
Kasparova, S.; Sumbalova, Z.; Bystricky, P.; Kucharska, J.; Liptaj, T.; Mlynarik, V.; Gvozdjakova, A., Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease. Neurochem Int, 2006, 48(2), 93-99. (Pubitemid 41832443)
-
(2006)
Neurochemistry International
, vol.48
, Issue.2
, pp. 93-99
-
-
Kasparova, S.1
Sumbalova, Z.2
Bystricky, P.3
Kucharska, J.4
Liptaj, T.5
Mlynarik, V.6
Gvozdjakova, A.7
-
114
-
-
33745120560
-
10 formulations in Huntington's disease mice
-
DOI 10.1016/j.bbadis.2006.03.004, PII S0925443906000482
-
Smith, K.M.; Matson, S.; Matson, W.R.; Cormier, K.; Del Signore, S.J.; Hagerty, S.W.; Stack, E.C.; Ryu, H.; Ferrante, R.J., Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochim Biophys Acta, 2006, 1762(6), 616-626. (Pubitemid 43903119)
-
(2006)
Biochimica et Biophysica Acta - Molecular Basis of Disease
, vol.1762
, Issue.6
, pp. 616-626
-
-
Smith, K.M.1
Matson, S.2
Matson, W.R.3
Cormier, K.4
Del Signore, S.J.5
Hagerty, S.W.6
Stack, E.C.7
Ryu, H.8
Ferrante, R.J.9
-
115
-
-
31644439986
-
10 in R6/2 transgenic Huntington's disease mice
-
DOI 10.1016/j.bbadis.2005.11.002, PII S0925443905001729
-
Stack, E.C.; Smith, K.M.; Ryu, H.; Cormier, K.; Chen, M.; Hagerty, S.W.; Del Signore, S.J.; Cudkowicz, M.E.; Friedlander, R.M.; Ferrante, R.J., Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochim Biophys Acta, 2006, 1762(3), 373-380. (Pubitemid 43172854)
-
(2006)
Biochimica et Biophysica Acta - Molecular Basis of Disease
, vol.1762
, Issue.3
, pp. 373-380
-
-
Stack, E.C.1
Smith, K.M.2
Ryu, H.3
Cormier, K.4
Chen, M.5
Hagerty, S.W.6
Del Signore, S.J.7
Cudkowicz, M.E.8
Friedlander, R.M.9
Ferrante, R.J.10
-
116
-
-
78149474887
-
Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline
-
Menalled, L.B.; Patry, M.; Ragland, N.; Lowden, P.A.; Goodman, J.; Minnich, J.; Zahasky, B.; Park, L.; Leeds, J.; Howland, D.; Signer, E.; Tobin, A.J.; Brunner, D., Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. PLoS One, 2010, 5(3), e9793.
-
(2010)
PLoS One
, vol.5
, Issue.3
-
-
Menalled, L.B.1
Patry, M.2
Ragland, N.3
Lowden, P.A.4
Goodman, J.5
Minnich, J.6
Zahasky, B.7
Park, L.8
Leeds, J.9
Howland, D.10
Signer, E.11
Tobin, A.J.12
Brunner, D.13
-
117
-
-
85009226418
-
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease
-
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology, 2001, 57(3), 397-404.
-
(2001)
Neurology
, vol.57
, Issue.3
, pp. 397-404
-
-
-
118
-
-
77956802394
-
Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects
-
Hyson, H.C.; Kieburtz, K.; Shoulson, I.; McDermott, M.; Ravina, B.; de Blieck, E.A.; Cudkowicz, M.E.; Ferrante, R.J.; Como, P.; Frank, S.; Zimmerman, C.; Ferrante, K.; Newhall, K.; Jennings, D.; Kelsey, T.; Walker, F.; Hunt, V.; Daigneault, S.; Goldstein, M.; Weber, J.; Watts, A.; Beal, M.F.; Browne, S.E.; Metakis, L.J., Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects. Mov Disord, 2010, 25(12), 1924-1928.
-
(2010)
Mov Disord
, vol.25
, Issue.12
, pp. 1924-1928
-
-
Hyson, H.C.1
Kieburtz, K.2
Shoulson, I.3
McDermott, M.4
Ravina, B.5
De Blieck, E.A.6
Cudkowicz, M.E.7
Ferrante, R.J.8
Como, P.9
Frank, S.10
Zimmerman, C.11
Ferrante, K.12
Newhall, K.13
Jennings, D.14
Kelsey, T.15
Walker, F.16
Hunt, V.17
Daigneault, S.18
Goldstein, M.19
Weber, J.20
Watts, A.21
Beal, M.F.22
Browne, S.E.23
Metakis, L.J.24
more..
-
119
-
-
77955036882
-
Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis
-
Crugnola, V.; Lamperti, C.; Lucchini, V.; Ronchi, D.; Peverelli, L.; Prelle, A.; Sciacco, M.; Bordoni, A.; Fassone, E.; Fortunato, F.; Corti, S.; Silani, V.; Bresolin, N.; Di Mauro, S.; Comi, G.P.; Moggio, M., Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol, 2010, 67(7), 849-854.
-
(2010)
Arch Neurol
, vol.67
, Issue.7
, pp. 849-854
-
-
Crugnola, V.1
Lamperti, C.2
Lucchini, V.3
Ronchi, D.4
Peverelli, L.5
Prelle, A.6
Sciacco, M.7
Bordoni, A.8
Fassone, E.9
Fortunato, F.10
Corti, S.11
Silani, V.12
Bresolin, N.13
Di Mauro, S.14
Comi, G.P.15
Moggio, M.16
-
120
-
-
77952638633
-
ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions
-
Keeney, P.M.; Bennett, J.P., Jr., ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions. Mol Neurodegener, 2010, 5, 21.
-
(2010)
Mol Neurodegener
, vol.5
, pp. 21
-
-
Keeney, P.M.1
Bennett Jr., J.P.2
-
121
-
-
10644241578
-
An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients
-
DOI 10.1016/j.jns.2004.09.030, PII S0022510X0400348X
-
Sohmiya, M.; Tanaka, M.; Suzuki, Y.; Tanino, Y.; Okamoto, K.; Yamamoto, Y., An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients. J Neurol Sci, 2005, 228(1), 49-53. (Pubitemid 39656494)
-
(2005)
Journal of the Neurological Sciences
, vol.228
, Issue.1
, pp. 49-53
-
-
Sohmiya, M.1
Tanaka, M.2
Suzuki, Y.3
Tanino, Y.4
Okamoto, K.5
Yamamoto, Y.6
-
122
-
-
33645068499
-
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS
-
Ferrante, K.L.; Shefner, J.; Zhang, H.; Betensky, R.; O'Brien, M.; Yu, H.; Fantasia, M.; Taft, J.; Beal, M.F.; Traynor, B.; Newhall, K.; Donofrio, P.; Caress, J.; Ashburn, C.; Freiberg, B.; O'Neill, C.; Paladenech, C.; Walker, T.; Pestronk, A.; Abrams, B.; Florence, J.; Renna, R.; Schierbecker, J.; Malkus, B.; Cudkowicz, M., Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology, 2005, 65(11), 1834-1836.
-
(2005)
Neurology
, vol.65
, Issue.11
, pp. 1834-1836
-
-
Ferrante, K.L.1
Shefner, J.2
Zhang, H.3
Betensky, R.4
O'Brien, M.5
Yu, H.6
Fantasia, M.7
Taft, J.8
Beal, M.F.9
Traynor, B.10
Newhall, K.11
Donofrio, P.12
Caress, J.13
Ashburn, C.14
Freiberg, B.15
O'Neill, C.16
Paladenech, C.17
Walker, T.18
Pestronk, A.19
Abrams, B.20
Florence, J.21
Renna, R.22
Schierbecker, J.23
Malkus, B.24
Cudkowicz, M.25
more..
-
123
-
-
70249116820
-
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
-
Kaufmann, P.; Thompson, J.L.; Levy, G.; Buchsbaum, R.; Shefner, J.; Krivickas, L.S.; Katz, J.; Rollins, Y.; Barohn, R.J.; Jackson, C.E.; Tiryaki, E.; Lomen-Hoerth, C.; Armon, C.; Tandan, R.; Rudnicki, S.A.; Rezania, K.; Sufit, R.; Pestronk, A.; Novella, S.P.; Heiman-Patterson, T.; Kasarskis, E.J.; Pioro, E.P.; Montes, J.; Arbing, R.; Vecchio, D.; Barsdorf, A.; Mitsumoto, H.; Levin, B., Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol, 2009, 66(2), 235-244.
-
(2009)
Ann Neurol
, vol.66
, Issue.2
, pp. 235-244
-
-
Kaufmann, P.1
Thompson, J.L.2
Levy, G.3
Buchsbaum, R.4
Shefner, J.5
Krivickas, L.S.6
Katz, J.7
Rollins, Y.8
Barohn, R.J.9
Jackson, C.E.10
Tiryaki, E.11
Lomen-Hoerth, C.12
Armon, C.13
Tandan, R.14
Rudnicki, S.A.15
Rezania, K.16
Sufit, R.17
Pestronk, A.18
Novella, S.P.19
Heiman-Patterson, T.20
Kasarskis, E.J.21
Pioro, E.P.22
Montes, J.23
Arbing, R.24
Vecchio, D.25
Barsdorf, A.26
Mitsumoto, H.27
Levin, B.28
more..
-
124
-
-
63349090059
-
Reactive oxygen species regulate DNA copy number in isolated yeast mitochondria by triggering recombination-mediated replication
-
Hori, A.; Yoshida, M.; Shibata, T.; Ling, F., Reactive oxygen species regulate DNA copy number in isolated yeast mitochondria by triggering recombination-mediated replication. Nucleic Acids Res, 2009, 37(3), 749-761.
-
(2009)
Nucleic Acids Res
, vol.37
, Issue.3
, pp. 749-761
-
-
Hori, A.1
Yoshida, M.2
Shibata, T.3
Ling, F.4
-
125
-
-
79957972977
-
Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis
-
Strobel, N.A.; Peake, J.M.; Matsumoto, A.; Marsh, S.A.; Coombes, J.S.; Wadley, G.D., Antioxidant Supplementation Reduces Skeletal Muscle Mitochondrial Biogenesis. Med Sci Sports Exerc, 2010.
-
(2010)
Med Sci Sports Exerc
-
-
Strobel, N.A.1
Peake, J.M.2
Matsumoto, A.3
Marsh, S.A.4
Coombes, J.S.5
Wadley, G.D.6
-
126
-
-
33847378451
-
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis
-
DOI 10.1001/jama.297.8.842
-
Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA, 2007, 297(8), 842-857. (Pubitemid 46333949)
-
(2007)
Journal of the American Medical Association
, vol.297
, Issue.8
, pp. 842-857
-
-
Bjelakovic, G.1
Nikolova, D.2
Gluud, L.L.3
Simonetti, R.G.4
Gluud, C.5
-
127
-
-
65549091910
-
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases
-
Yang, L.; Calingasan, N.Y.; Wille, E.J.; Cormier, K.; Smith, K.; Ferrante, R.J.; Beal, M.F., Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J Neurochem, 2009, 109(5), 1427-1439.
-
(2009)
J Neurochem
, vol.109
, Issue.5
, pp. 1427-1439
-
-
Yang, L.1
Calingasan, N.Y.2
Wille, E.J.3
Cormier, K.4
Smith, K.5
Ferrante, R.J.6
Beal, M.F.7
-
128
-
-
79955528923
-
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection
-
Wen, Y.; Li, W.; Poteet, E.C.; Xie, L.; Tan, C.; Yan, L.J.; Ju, X.; Liu, R.; Qian, H.; Marvin, M.A.; Goldberg, M.S.; She, H.; Mao, Z.; Simpkins, J.W.; Yang, S.H., Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem, 2011, 286(18), 16504-15.
-
(2011)
J Biol Chem
, vol.286
, Issue.18
, pp. 16504-16515
-
-
Wen, Y.1
Li, W.2
Poteet, E.C.3
Xie, L.4
Tan, C.5
Yan, L.J.6
Ju, X.7
Liu, R.8
Qian, H.9
Marvin, M.A.10
Goldberg, M.S.11
She, H.12
Mao, Z.13
Simpkins, J.W.14
Yang, S.H.15
|